Arthritis Advisory Committee: Notice of Postponement of Meeting

---
identifier: "/us/fr/2015-05527"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Arthritis Advisory Committee: Notice of Postponement of Meeting"
title_number: 0
title_name: "Federal Register"
section_number: "2015-05527"
section_name: "Arthritis Advisory Committee: Notice of Postponement of Meeting"
positive_law: false
currency: "2015-03-11"
last_updated: "2015-03-11"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2015-05527"
document_type: "notice"
publication_date: "2015-03-11"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
fr_citation: "80 FR 12823"
fr_volume: 80
docket_ids:
  - "Docket No. FDA-2015-N-0001"
fr_action: "Notice."
---


#  Arthritis Advisory Committee: Notice of Postponement of Meeting

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Notice.

**SUMMARY:**

The Food and Drug Administration (FDA) is postponing the meeting of the Arthritis Advisory Committee scheduled for March 17, 2015. The meeting was announced in the *Federal Register* of February 10, 2015 (80 FR 7480). The postponement is due to information requests pending with the sponsor of the application. A future meeting date will be announced in the *Federal Register* .

**FOR FURTHER INFORMATION CONTACT:**

Stephanie L. Begansky, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 31, Rm. 2417, Silver Spring, MD 20993-0002, 301-796-9001, FAX: 301-847-8533, email: *[email protected],* or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area). Please call the Information Line for up-to-date information on this meeting.

Dated: March 6, 2015.

Leslie Kux,

Associate Commissioner for Policy.